Skip to main content

MARATHON CAPITAL MANAGEMENT

Position in ANIP — Ani Pharmaceuticals Inc

CIK 1213206 Hunt Valley, MD

Position in ANIP

as of Jun 30, 2026 · filed Jul 22, 2026
Position Value
$5,959,332
+$377,161 QoQ
Shares Held
71,990
-0.8% QoQ
Ownership
0.313%
of shares outstanding
% of Portfolio
1.37%
of 13F equity value
Holder Rank
#67
of 303 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority Sole 2% Shared 0% None 98%

Common Shares in ANIP Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

MARATHON CAPITAL MANAGEMENT holds $11,964,744 across 2 Drug Manufacturers - Specialty & Generic names. ANIP ranks #2 (49.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 ANIP
Ani Pharmaceuticals Inc
This page
71,990 $5,959,332

All Filings in ANIP

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,959,332 71,990
2026-03-31 $5,582,171 72,590
2025-12-31 $5,499,355 69,665
2025-09-30 $6,384,978 69,705
2025-06-30 $4,699,631 72,025
2025-03-31 $4,632,605 69,195
2024-12-31 $3,863,795 69,895
2024-09-30 $4,178,884 70,045
2024-06-30 $4,476,385 70,295
2024-03-31 $4,919,982 71,170
2023-12-31 $3,849,874 69,820
2023-09-30 $4,161,160 71,670
2023-06-30 $3,695,160 68,645
2023-03-31 $3,371,830 84,890
2022-12-31 $2,932,364 72,890
2022-09-30 $2,342,684 72,890
2022-06-30 $2,209,228 74,460
2022-03-31 $2,108,531 75,010
2021-12-31 $3,445,401 74,770
2021-09-30 $2,435,079 74,195